ELOXX PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

(a) The annual meeting of stockholders of Eloxx Pharmaceuticals, Inc. (the "Company") was held on May 19, 2021.

(b) Stockholders voted on the matters set forth below:

Proposal 1. Election of Directors:

                           For           Withheld        Broker Non-Votes
Tomer Kariv              19,259,075         937,323              5,837,608
Sumit Aggarwal           20,095,235         101,163              5,837,608
Zafrira Avnur, Ph.D.     19,259,792         936,606              5,837,608
Ran Nussbaum             18,926,489       1,269,909              5,837,608
Rajesh Parekh, DPhil     20,136,166          60,232              5,837,608
Steven Rubin             17,365,649       2,830,749              5,837,608
Jasbir Seehra, Ph.D.     20,091,721         104,677              5,837,608
Gadi Veinrib             20,093,317         103,081              5,837,608
Alan Walts, Ph.D.        19,901,777         294,621              5,837,608

Proposal 2. Ratification of Appointment Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2021:

For                  25,998,455
Against                   9,022
Abstain                  26,529
Broker Non-Votes      5,837,608

Proposal 3. Advisory Vote on Executive Compensation:

For                  20,065,552
Against                  98,341
Abstain                  32,505
Broker Non-Votes      5,837,608




(c) Not applicable.

(d) Not applicable.

© Edgar Online, source Glimpses